Health & bio

Eli Lilly Launches Foundayo (Orforglipron)

First small-molecule GLP-1 oral agent; 11% weight loss in clinical trials.

Primary sources · 1
Eli Lilly
← View the full 2026-04-22 (Wed) issue
What you're reading now arrives in your inbox daily at 21:00 UTC.

Get today's brief every day at 21:00 UTC

7 must-reads · 17 fields · tracked storylines delivered to your inbox daily. Pick only the fields you want; unsubscribe anytime.

Past issues →